ECTRIMS 2019: A novel platform for addressing MS pathology and heterogeneity

Galina Zheleznyakova | ECTRIMS 2019 | 13. September 2019

ECTRIMS 2019: The MS Atlas – ...
- Speaker: Tobias Frisch & Maria Louise Elkjær
- Spilletid: 4:05
ECTRIMS 2019: Monitoring disease ac ...
- Speaker: Jan Lycke
- Spilletid: 3:16
ECTRIMS 2019: Neurofilament levels ...
- Speaker: Henrik Lundell
- Spilletid: 2:41
ECTRIMS 2019: Dramatic shortening o ...
- Speaker: Leszek Stawiarz
- Spilletid: 2:17
ECTRIMS 2019: Detecting rare MOG sp ...
- Speaker: Mattias Bronge
- Spilletid: 2:54
ECTRIMS 2019: Efficacy of satralizu ...
- Speaker: Jeffrey L Bennett
- Spilletid: 4:09
ECTRIMS 2019: Vacciner er ikke en r ...
- Speaker: Jette Lautrup Frederiksen
- Spilletid: 3:55
ECTRIMS 2019: First international d ...
- Speaker: Per Soelberg
- Spilletid: 2:13
ECTRIMS 2019: The evidence of cogni ...
- Speaker: Päivi Hämäläinen
- Spilletid: 1:58
ECTRIMS 2019: Use of fingolimod in ...
- Speaker: Finn Sellebjerg
ECTRIMS 2019: Dimethyl fumarate per ...
- Speaker: Tobias Sejbæk Mathiesen
- Spilletid: 2:32
ECTRIMS 2019: Leptin levels are ass ...
- Speaker: Martin Biström
- Spilletid: 3:36
ECTRIMS 2019: Impact of age on trea ...
- Speaker: Per Solberg
ECTRIMS 2019: School performance an ...
- Speaker: Magnus Spangsberg Boesen
- Spilletid: 3:31
ECTRIMS 2019: Cladribine modifies f ...
- Speaker: Line Jørgensen
- Spilletid: 2:34
ECTRIMS 2019: The prognosis of neur ...
- Speaker: Nasrin  Asgari
- Spilletid: 3:42
ECTRIMS 2019: The risk of disabilit ...
- Speaker: Emilio Portaccio
- Spilletid: 1:48
ECTRIMS 2019: Pregnancy in women wi ...
- Speaker: Emilio Portaccio
- Spilletid: 1:40
ECTRIMS 2019: Promising insights in ...
- Speaker: Majid Pahlevan
- Spilletid: 3:31
ECTRIMS 2019: Epilepsy in MS are as ...
- Speaker: Zamzam Mahamud
- Spilletid: 3:31
ECTRIMS 2019: Natalizumab usage in ...
- Speaker: Jeppe Romme Christensen
- Spilletid: 6:07
ECTRIMS 2019: Serious cardiovascula ...
- Speaker: Thomas Frisell
- Spilletid: 1:57
ECTRIMS 2019: Safety and efficacy o ...
- Speaker: Øivind Fredvik Torkildsen
- Spilletid: 2:46
ECTRIMS 2019: Alemtuzumab treatment ...
- Speaker: Asta Theodorsdottir
- Spilletid: 1:57
ECTRIMS 2019: Evaluation of rapid s ...
- Speaker: Claudia Pfleger
- Spilletid: 2:18
ECTRIMS 2019: Differentially expres ...
- Speaker: Tone Berge
- Spilletid: 3:18
ECTRIMS 2019: Postpartum relapse af ...
- Speaker: Elisabeth Gulowsen Celius
- Spilletid: 2:33
ECTRIMS 2019: Personalized medicine ...
- Speaker: Hanne Harbo
- Spilletid: 4:45
ECTRIMS 2019: The future of MS-trea ...
- Speaker: Lars Bø
- Spilletid: 3:06
ECTRIMS 2019: Bridging the MS pract ...
- Speaker: Jan Hillert
- Spilletid: 2:41
ECTRIMS 2019: Danish experience wit ...
- Speaker: Alex Heick
- Spilletid: 3:56
ECTRIMS 2019: Longitudinal brain ag ...
- Speaker: Einar Høgestøl
- Spilletid: 2:31
ECTRIMS 2019: Pregnancy related and ...
- Speaker: Johanna Balslev Andersen
- Spilletid: 2:22
ECTRIMS 2019: Cladribine as treatme ...
- Speaker: Elisabeth Gulowsen Celius
- Spilletid: 3:10
ECTRIMS 2019: MS alters white matte ...
- Speaker: Linda Karin Margriet Sundvall Germeys
- Spilletid: 4:14
ECTRIMS 2019: Long term effect of d ...
- Speaker: Tine Iskov Kopp
- Spilletid: 2:37
ECTRIMS 2019: Patient awareness abo ...
- Speaker: Marie B D'hooghe
- Spilletid: 2:37

Speaker: Galina Zheleznyakova

Galina Zheleznyakova have dentified a number of different sncRNAs where further research may pave the way for identification of informative biomarkers and possible treatment targets. In this MEdtalk she present the result from the study.